[INM] YoY Quarter Result on 30-Sep-2023 [#Q1]

Stock
[INM] InMed Pharmaceuticals Inc.
Announcement Date
13-Nov-2023
Financial Year
2024
Quarter
30-Sep-2023 [#Q1]
Profit Trend
QoQ- -650.59%
YoY- 27.72%
Quarter Report
INM's Result
INM's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
Revenue 1,690 321 0 0 0 0 0 -
PBT -2,537 -3,503 -2,972 -1,599 -2,936 -2,199 -1,467 9.55%
Tax 12 7 79 35 -74 -42 4 20.08%
NP -2,537 -3,510 -2,972 -1,599 -2,936 -2,199 -1,467 9.55%
Tax Rate - - - - - - - -
Total Cost 4,226 3,831 2,972 1,599 2,936 2,199 1,467 19.27%
Ratio Analysis
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
NP Margin -150.15 -1,094.24 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
EPS -0.76 -4.06 -6.17 -7.66 -14.06 -10.62 -9.25 -34.05%
EPS Diluted -0.76 -4.06 -6.17 -7.66 -14.06 -10.62 -9.25 -34.05%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.